IPCALAB:NSE
IPCA Laboratories Ltd
₹1,889.90
arrow_downward
-0.52%(-9.80) 1D
Nov 13, 3:30:00 PM GMT+5:30 · INR
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for IPCALAB...
Open
₹1,900.10
High
₹1,935.40
Low
₹1,868.40
Mkt. cap
477.98B
Avg. vol.
271.71K
Volume
232.74K
Dividend
0.32%
Quarterly dividend
₹1.50
Ex-dividend date
Aug 7, 2026
P/E ratio
34.19
52-wk high
₹2,038.00
52-wk low
₹1,293.90
EPS
₹55.28
Shares outstanding
126.35M
No. of employees
17K
Open
₹1,900.10
High
₹1,935.40
Low
₹1,868.40
Mkt. cap
477.98B
Avg. vol.
271.71K
Volume
232.74K
Dividend
0.32%
Quarterly dividend
₹1.50
Ex-dividend date
Aug 7, 2026
P/E ratio
34.19
52-wk high
₹2,038.00
52-wk low
₹1,293.90
EPS
₹55.28
Shares outstanding
126.35M
No. of employees
17K
News stories
From web sources and news partners
TheStreet
·
2 hours ago
Berkshire’s record high exposes hidden trap in S&P 500 401(k) plans
www.foreignpolicyjournal.com
·
12 minutes ago
GE Vernova (NYSE: GEV) Faces Ontario Nuclear Cost Overruns Even As Hydrogen Turbine Validation Advances
Yahoo Finance
·
2 days ago
Stock market today: Dow, S&P 500, Nasdaq futures edge higher after wholesale inflation grows, Nvidia stock rebounds
Foreign Policy Journal
·
33 minutes ago
RTX Corp (NYSE: RTX) Trades At A P/E Premium To Defense Peers Even As $340B Backlog Fuels Bullish Case
Profile
Ipca Laboratories Limited is an Indian multinational pharmaceutical company headquartered in Mumbai. The company manufactures and markets more than 350 finished-dosage formulations and around 80 active pharmaceutical ingredients, covering therapeutic areas that include pain management, rheumatology, antimalarials, cardiovascular medicine, dermatology and anti-diabetics, and has an emerging biosimilars business. Its products are sold in over 100 countries, and it is one of India's larger API exporters, supplying more than 70 countries.
Ipca is one of the largest global suppliers of the antimalarials hydroxychloroquine and chloroquine, as well as of APIs such as atenolol, chlorthalidone, losartan and metoprolol. Since 2023, it has held a majority stake in Unichem Laboratories. The company is listed on the BSE and the National Stock Exchange of India, and reported consolidated revenue of ₹9,646 crore in the financial year ended 31 March 2026. Wikipedia
About IPCA Laboratories Ltd
CEO-
Employees17.2K
FoundedOct 19, 1949
Headquarters-
SectorHealth Care
IndustryPharmaceutical industry
Websiteipca.com